AB — AB Science SA Income Statement
0.000.00%
Last trade - 00:00- €75.84m
- €85.76m
- €0.97m
Annual income statement for AB Science SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | — | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.57 | 1.58 | 1.61 | 0.958 | 0.97 |
| Cost of Revenue | |||||
| Gross Profit | 1.39 | 1.51 | 1.5 | 0.927 | 0.587 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 19 | 16.3 | 15.4 | 16.9 | 14.4 |
| Operating Profit | -17.5 | -14.7 | -13.8 | -15.9 | -13.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -21.7 | -15 | -14.4 | -13.6 | -12 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -21.7 | -15 | -14.5 | -13.6 | -12 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -21.7 | -15 | -14.5 | -13.6 | -12 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -21.7 | -15 | -14.5 | -13.6 | -12 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.552 | -0.34 | -0.304 | -0.289 | -0.241 |
| Dividends per Share |